LexDanaLexDanabeta
Inventor

KARL RICHARD GIBSON

Inventor
GB

Overview

5→
Patents
2021–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
11,993,595Compounds202411,660,293Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists202311,472,798Compounds202211,400,081Compounds202211,136,325Pyrrolopyrimidine and pyrrolopyridine derivatives2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021Patents assigned to GALAPAGOS NV (1)· patent assignee history
2021–2024Based in GB· patent location history
2022–2024Patents assigned to MISSION THERAPEUTICS LTD (2)· patent assignee history
2022Patents assigned to UNIV SHEFFIELD (1)· patent assignee history
2023Patents assigned to CHRONOS THERAPEUTICS LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MISSION THERAPEUTICS LTD22022–2024
CHRONOS THERAPEUTICS LTD12023
GALAPAGOS NV12021
UNIV SHEFFIELD12022
Locations
LocationPatentsSpan
GB52021–2024